Delivery Order SPE2DB24D1021-SPE2DB25FETHS
Award Date
1/17/25
Potential Completion Date
1/21/25
Potential Value
$32K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,507.63, is for the delivery of 60 tablets of the medication Valganciclovir 450 mg. The contract has a firm fixed price and an ultimate completion date of November 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,605.14, is for the delivery of 60 count valganciclovir 450 mg tablets. It is a firm-fixed price delivery order with a completion date of December 5, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,395.13 Firm Fixed Price delivery order is for the supply of 60 units of the prescription drug Valganciclovir 450 mg tablets. The contract has an ultimate completion date of February 8, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,349.44 firm fixed-price contract is for the delivery of 4559897831 - Valganciclovir 450 mg tablets. The award is not set aside for any particular business type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Valganciclovir 450 mg tablets. The $1,044.98 firm-fixed-price contract has a performance period through May 2, 2022. This contract is not designated as a set-aside award. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division to provide a wide...
This is a $2,458.82 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4567117522 valganciclovir HCL 50 mg/ml 88ml, a specialty medication. The award date is January 31, 2025, with a completion date of February 3, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued...
This federal contract award is for the supply of Valganciclovir HCL 50 mg/ml, 88 ml, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, with a ceiling value of $1,482.04. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive...
This federal contract award is a delivery order (SPE2DB22D3004|SPE2DB25FPH63) issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,055.37 firm fixed-price contract is for the supply of valganciclovir HCL 50 mg/ml, an antiviral medication, to support military healthcare programs. The contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DX15D1053|SPE2DX24F6HVT, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,163.63 firm fixed-price delivery order is for the supply of valganciclovir hydrochloride 50 mg/ml, 88 ml. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor...
This federal contract award is for the delivery of Valacyclovir HCl 1 gram tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,940.28 fixed-price delivery order was issued to the prime contractor, AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of December 2, 2024 and was awarded on November 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...